PVMCV
Polaris Venture Management Co V Portfolio holdings
AUM
$14.1M
This Quarter Return
+23.37%
1 Year Return
+121.41%
3 Year Return
+278.88%
5 Year Return
+1,121.38%
10 Year Return
–
AUM
$127M
AUM Growth
+$127M
(+7.7%)
Cap. Flow
-$22.6M
Cap. Flow
% of AUM
-17.77%
Top 10 Holdings %
Top 10 Hldgs %
99.52%
Holding
12
New
–
Increased
–
Reduced
3
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
ATYR
aTyr Pharma
ATYR
|
$8.71M |
| 2 |
Cardlytics
CDLX
|
$7.15M |
| 3 |
GNCA
Genocea Biosciences, Inc.
GNCA
|
$6.75M |
Sector Composition
| 1 | Healthcare | 51.09% |
| 2 | Communication Services | 46.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cardlytics
CDLX
$54.3M
| $59.2M | 46.48% | 2,277,342 -275,284 | -11% | -$7.15M |
|
2
Fate Therapeutics
FATE
$120M
| $29.9M | 23.49% | 1,473,186 | – | – |
|
3
KALA BIO
KALA
$78.8M
| $11.9M | 9.31% | 1,857,582 | – | – |
|
4
Neuronetics
STIM
$220M
| $9.29M | 7.29% | 742,289 | – | – |
|
5
Cartesian Therapeutics
RNAC
$261M
| $4.97M | 3.9% | 2,773,479 | – | – |
|
6
X4 Pharmaceuticals
XFOR
$84.2M
| $4.67M | 3.67% | 311,492 | – | – |
|
|
TTOO
7
DELISTED
T2 Biosystems, Inc
TTOO
| $3.09M | 2.43% | 1,841,924 | – | – |
|
|
TRVN
8
DELISTED
Trevena, Inc.
TRVN
| $2.12M | 1.66% | 2,053,540 | – | – |
|
|
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
| $965K | 0.76% | 246,078 -1,722,528 | -87% | -$6.75M |
|
|
ATYR
10
aTyr Pharma
ATYR
$527M
| $670K | 0.53% | 130,571 -1,697,421 | -93% | -$8.71M |
|
11
Pulmatrix
PULM
$18M
| $331K | 0.26% | 359,438 | – | – |
|
12
Dare Bioscience
DARE
$27.2M
| $277K | 0.22% | 326,243 | – | – |
|